Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Insmed Incorporated, 3 years.
Insmed Incorporated
Director
BioMarin Pharmaceutical Inc.
Director
Revolution Medicines Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Revolution Medicines Inc. | Option exercise | +5,070 | $1.12 | $5,678 |
| Sep 22, 2026 | Revolution Medicines Inc. | Open-market sale | −910 | $191.85 | $174,585 |
| Sep 22, 2026 | Revolution Medicines Inc. | Open-market sale | −4,985 | $192.54 | $959,805 |
| Sep 22, 2026 | Revolution Medicines Inc. | Open-market sale | −2,648 | $193.44 | $512,227 |
| Sep 22, 2026 | Revolution Medicines Inc. | Open-market sale | −1,500 | $194.59 | $291,883 |
| Sep 22, 2026 | Revolution Medicines Inc. | Open-market sale | −100 | $195.15 | $19,515 |
| Jun 18, 2026 | Revolution Medicines Inc. | Grant or award | +1,191 | — | — |
| Jun 2, 2026 | BioMarin Pharmaceutical Inc. | Grant or award | +7,490 | — | — |
| May 13, 2026 | Insmed Incorporated | Grant or award | +3,305 | — | — |
| Mar 4, 2026 | Revolution Medicines Inc. | Gift | −15,000 | — | — |
| Mar 4, 2026 | Revolution Medicines Inc. | Gift | +15,000 | — | — |
| Nov 24, 2025 | Insmed Incorporated | Open-market sale | −5,000 | $204.58 | $1,022,900 |
| Nov 14, 2025 | Insmed Incorporated | Open-market sale | −10,000 | $195.87 | $1,958,700 |
| Jun 26, 2025 | Revolution Medicines Inc. | Grant or award | +3,142 | — | — |
| May 20, 2025 | BioMarin Pharmaceutical Inc. | Grant or award | +6,650 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.